Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: diabetes
A new review suggests GLP-1 medications may influence brain function, though clinical trials for Alzheimer’s have shown mixed results regarding cognitive preservation.
A pioneering scheme in Cornwall provides free vegetables and cooking classes to patients with type 2 diabetes, helping participants lower their blood sugar levels.
North Dakota has joined 29 states in enacting an insulin price cap, limiting out-of-pocket costs for patients to $25 a month in a rare bipartisan healthcare victory.
Researchers at ETH Zurich developed an electronic implant that converts excess glucose into gluconate, lowering blood sugar and promoting weight loss in diabetic mice.
New research published in Neurology links high consumption of low-calorie sweeteners to faster cognitive decline, particularly in adults under 60 and people with diabetes.
New research from Rutgers University identifies a small increase in the risk of ischemic optic neuropathy among patients taking GLP-1 medications like Ozempic and Wegovy.
A comprehensive review reveals how immune cells like macrophages and neutrophils fail to transition from inflammation to repair, stalling diabetic wound healing.
